Korean Coronary Bifurcation Stenting (COBIS) Registry III — COBIS III

Coronary Bifurcation Lesion Clinical Trial

Official title:
Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III

Status Completed

Clinical Trial Summary

The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Coronary Bifurcation Lesion

Clinical Trial Details

NCT number	NCT03068494
Study type	Observational [Patient Registry]
Source	Samsung Medical Center
Contact
Status	Completed
Phase
Start date	February 28, 2017
Completion date	December 29, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05731687` - Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy	N/A
Not yet recruiting	`NCT01300494` - BOVAS: Bifurcation Optimal Viewing Angle Selection Study	N/A
Completed	`NCT01642992` - Korean Coronary Bifurcation Stenting (COBIS) Registry II	N/A
Completed	`NCT00851526` - Coronary Bifurcation Stenting (COBIS) Registry in South Korea	N/A
Recruiting	`NCT03450577` - International Bifurcation Study
Not yet recruiting	`NCT04471883` - LATAM Bif Registry